Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey.

Simple item page
dc.contributor.authorNelson, Karin
dc.contributor.authorNorris, Keith
dc.contributor.authorMangione, Carol M
dc.date.accessioned2019-08-14T15:06:41Z
dc.date.available2019-08-14T15:06:41Z
dc.date.issued2002
dc.description.abstractAfrican Americans and Mexican Americans were less likely to report serum cholesterol screening than whites. Even when identified as having high cholesterol that required medication, African Americans and Mexican Americans were less likely than whites to be taking cholesterol-lowering agents.
dc.description.urihttp://archinte.ama-assn.org/cgi/content/full/162/8/929
dc.identifierhttps://doi.org/10.13016/pxzt-rex3
dc.identifier.citationNelson, Karin and Norris, Keith and Mangione, Carol M (2002) Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Archives of internal medicine, 162 (8). pp. 929-935.
dc.identifier.issn0003-9926
dc.identifier.otherEprint ID 3698
dc.identifier.urihttp://hdl.handle.net/1903/24235
dc.subjectDisparities
dc.subjectPharmacotherapy
dc.subjectstudies
dc.titleDisparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey.
dc.typeArticle

Files

Collections

Minority Health and Health Equity Archive